University at Buffalo (UB)
Dr. Hingtgen is an Assistant Professor in the Eshelmen School of Pharmacy at the University of North Carolina-Chapel Hill. He works in the Division of Molecular Pharmaceutics and in particular, in glioblastoma, or GBM. His seminar will cover stem cell-based therapies and how they hold the potential to redefine therapeutic approaches and provide cures for many terminal diseases. His group works on a relatively unknown aspect of stem cells: they naturally seek out cancer. They harness this tumor-homing property and ability to function as in situ drug pumps to develop new stem cell-based therapies for cancer, including brain cancer.
Shaweta Gupta
Email: sg98@buffalo.edu
Phone: (716) 829 6268